Your browser doesn't support javascript.
loading
Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial.
Atkins, Michael B; Plimack, Elizabeth R; Puzanov, Igor; Fishman, Mayer N; McDermott, David F; Cho, Daniel C; Vaishampayan, Ulka; George, Saby; Olencki, Thomas E; Tarazi, Jamal C; Rosbrook, Brad; Fernandez, Kathrine C; Lechuga, Mariajose; Choueiri, Toni K.
Affiliation
  • Atkins MB; Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC, USA. Electronic address: mba41@georgetown.edu.
  • Plimack ER; Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Puzanov I; Vanderbilt University Medical Center, Nashville, TN, USA; Roswell Park Cancer Institute, Buffalo, NY, USA.
  • Fishman MN; Moffitt Cancer Center, Tampa, FL, USA.
  • McDermott DF; Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Cho DC; New York University Langone Medical Center, New York, NY, USA.
  • Vaishampayan U; Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.
  • George S; Roswell Park Cancer Institute, Buffalo, NY, USA.
  • Olencki TE; Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Tarazi JC; Pfizer Oncology, San Diego, CA, USA.
  • Rosbrook B; Pfizer Oncology, San Diego, CA, USA.
  • Fernandez KC; Pfizer Oncology, Cambridge, MA, USA.
  • Lechuga M; Pfizer SrL, Milan, Italy.
  • Choueiri TK; Dana-Farber Cancer Institute, Boston, MA, USA.
Lancet Oncol ; 19(3): 405-415, 2018 03.
Article in En | MEDLINE | ID: mdl-29439857
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Renal Cell / Antineoplastic Combined Chemotherapy Protocols / Angiogenesis Inhibitors / Antibodies, Monoclonal, Humanized / Antineoplastic Agents, Immunological / Axitinib / Kidney Neoplasms Type of study: Clinical_trials / Diagnostic_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2018 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Renal Cell / Antineoplastic Combined Chemotherapy Protocols / Angiogenesis Inhibitors / Antibodies, Monoclonal, Humanized / Antineoplastic Agents, Immunological / Axitinib / Kidney Neoplasms Type of study: Clinical_trials / Diagnostic_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2018 Type: Article